Precision medicine in diabetes

J Pak Med Assoc. 2019 Sep;69(9):1394-1395.

Abstract

This review presents the dynamic and fast growing concept of precision medicine in a simple and succinct manner. It describes the potential of precision medicine in diabetes praxis, under three headings: diagnosis of type of diabetes, choice of pharmacotherapy for glucose lowering, and management of complications of diabetes. This review should make the scope of precision medicine easy to understand for the practicing physician.

Keywords: Genes, metformin, monogenic diabetes, repaglinide, sulfonylureas, incretins..

Publication types

  • Review

MeSH terms

  • Diabetes Complications / drug therapy*
  • Diabetes Mellitus / diagnosis*
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / genetics
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Precision Medicine*

Substances

  • Hypoglycemic Agents